Product | MedDrive®
INFOGRAPHIC
Leveraging the collective strength of Prime’s client membership to help control medical costs including biosimilars, medical rebates and low net cost savings.
Related news
Press releases
May 26, 2021
Prime Therapeutics launches MedDrive™, a first-of-its kind medical drug management program uniquely aligned with its Blue Plan clients
EAGAN, Minn. – Today, Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM)…
Press releases
November 3, 2021
Prime Therapeutics backs first interchangeable insulin biosimilar Semglee®
EAGAN, Minn. – Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM)…
Stories
September 8, 2021
Prime leaders appear on PCMA’s podcast on topic “Understanding the value of biosimilars”
Today, spending on biologic drugs makes up 43% of total drug spending. This…